Publication | Closed Access

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

Esophageal CancerMedicinePathologyRandomized Phase 3Cancer TreatmentFirst-line SugemalimabOncologyRadiation OncologyTumor MicroenvironmentCancer Research